Exocrine Pancreatic Insufficiency Induced by Immune Checkpoint Inhibitors.

ICI-related EPI is a rare but clinically significant event that should be considered in patients with late onset diarrhea after ICI treatment and often is associated with development of hyperglycemia and diabetes.